Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 1;4(11):1174-1175.
doi: 10.1001/jamacardio.2019.3796.

Implications of Specialist Density for Diabetes Care in the United States

Affiliations

Implications of Specialist Density for Diabetes Care in the United States

Ravi B Patel et al. JAMA Cardiol. .

Abstract

This Research Letter examines the distribution of US internal medicine specialists who are able to provide diabetes care.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Patel is supported by National Heart, Lung, and Blood Institute T32 postdoctoral training grant T32HL069771. Dr Vaduganathan is supported by the KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst (National Institutes of Health [NIH]/National Center for Advancing Translational Sciences award UL 1TR002541); serves on advisory boards for Amgen, AstraZeneca, Baxter Healthcare, Bayer AG, and Boehringer Ingelheim; and participates on clinical end point committees for studies sponsored by Novartis and the NIH. No other disclosures were reported.

Figures

Figure.
Figure.. Density of Newly Diagnosed Cases of Diabetes per Specialist in 2016 Across US States
A, Cardiologists. The estimates vary from 30:1 to 154:1 across states. B, Endocrinologists. The estimates vary from 37:1 to 667:1 across states. C, Nephrologists. The estimates vary from 46:1 to 2000:1 across states. Density maps of the number of incident diabetes cases per specialist were created using Microsoft Excel with Bing software (GeoNames, HERE, MSFT).

Comment in

References

    1. Vaduganathan M, Patel RB, Singh A, et al. Prescription of glucagon-like peptide-1 receptor agonists by cardiologists. J Am Coll Cardiol. 2019;73(12):1596-1598. doi: 10.1016/j.jacc.2019.01.029 - DOI - PMC - PubMed
    1. Vaduganathan M, Sathiyakumar V, Singh A, et al. Prescriber patterns of SGLT2i after expansions of U.S. Food and Drug Administration labeling. J Am Coll Cardiol. 2018;72(25):3370-3372. doi: 10.1016/j.jacc.2018.08.2202 - DOI - PubMed
    1. Davidson JA. The increasing role of primary care physicians in caring for patients with type 2 diabetes mellitus. Mayo Clin Proc. 2010;85(12)(suppl):S3-S4. doi: 10.4065/mcp.2010.0466 - DOI - PMC - PubMed
    1. Gunawan F, Partridge C, Kosiborod M, et al. Cardiologist vs. endocrinologist encounters in patients with T2D and CVD: potential implications for glucose-lowering therapy use and education. Paper presented at: Endocrine Society Annual Meeting; March 23-26, 2019; New Orleans, LA. https://academic.oup.com/jes/article/3/Supplement_1/SUN-149/5483577. Accessed May 1, 2019.
    1. Centers for Disease Control and Prevention US Diabetes Surveillance System. http://www.cdc.gov/diabetes/data. Accessed April 21, 2019.

MeSH terms